nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—schizophrenia—Dimenhydrinate—atopic dermatitis	0.295	0.569	CpDpCtD
Valproic Acid—schizophrenia—Diphenhydramine—atopic dermatitis	0.223	0.431	CpDpCtD
Valproic Acid—CYP2C18—Diphenhydramine—atopic dermatitis	0.0534	0.156	CbGbCtD
Valproic Acid—SLC22A5—Diphenhydramine—atopic dermatitis	0.0341	0.0999	CbGbCtD
Valproic Acid—CYP2C8—Mometasone—atopic dermatitis	0.0223	0.0652	CbGbCtD
Valproic Acid—PTGS1—Diphenhydramine—atopic dermatitis	0.0222	0.0649	CbGbCtD
Valproic Acid—CYP3A5—Tacrolimus—atopic dermatitis	0.0182	0.0532	CbGbCtD
Valproic Acid—CYP2B6—Diphenhydramine—atopic dermatitis	0.0169	0.0494	CbGbCtD
Valproic Acid—CYP2A6—Prednisolone—atopic dermatitis	0.0152	0.0446	CbGbCtD
Valproic Acid—CYP2C8—Loratadine—atopic dermatitis	0.0128	0.0374	CbGbCtD
Valproic Acid—CYP3A4—Pimecrolimus—atopic dermatitis	0.0119	0.0349	CbGbCtD
Valproic Acid—CYP2C19—Loratadine—atopic dermatitis	0.0107	0.0314	CbGbCtD
Valproic Acid—CYP2C19—Diphenhydramine—atopic dermatitis	0.0107	0.0314	CbGbCtD
Valproic Acid—CYP1A2—Diphenhydramine—atopic dermatitis	0.00991	0.029	CbGbCtD
Valproic Acid—CYP2A6—Dexamethasone—atopic dermatitis	0.00898	0.0263	CbGbCtD
Valproic Acid—CYP2C9—Diphenhydramine—atopic dermatitis	0.00893	0.0261	CbGbCtD
Valproic Acid—CYP2C9—Loratadine—atopic dermatitis	0.00893	0.0261	CbGbCtD
Valproic Acid—CYP3A5—Hydrocortisone—atopic dermatitis	0.00741	0.0217	CbGbCtD
Valproic Acid—CYP2C8—Hydrocortisone—atopic dermatitis	0.00712	0.0208	CbGbCtD
Valproic Acid—CYP3A4—Tacrolimus—atopic dermatitis	0.00709	0.0207	CbGbCtD
Valproic Acid—CYP2C19—Prednisone—atopic dermatitis	0.00595	0.0174	CbGbCtD
Valproic Acid—CYP2B6—Dexamethasone—atopic dermatitis	0.00585	0.0171	CbGbCtD
Valproic Acid—CYP3A4—Loratadine—atopic dermatitis	0.00519	0.0152	CbGbCtD
Valproic Acid—CYP3A4—Methylprednisolone—atopic dermatitis	0.00475	0.0139	CbGbCtD
Valproic Acid—CYP3A5—Dexamethasone—atopic dermatitis	0.00461	0.0135	CbGbCtD
Valproic Acid—CYP2C8—Dexamethasone—atopic dermatitis	0.00443	0.013	CbGbCtD
Valproic Acid—CYP2C19—Dexamethasone—atopic dermatitis	0.00372	0.0109	CbGbCtD
Valproic Acid—CYP3A4—Triamcinolone—atopic dermatitis	0.0036	0.0105	CbGbCtD
Valproic Acid—CYP2C9—Dexamethasone—atopic dermatitis	0.00309	0.00903	CbGbCtD
Valproic Acid—CYP3A4—Betamethasone—atopic dermatitis	0.00309	0.00903	CbGbCtD
Valproic Acid—CYP3A4—Prednisolone—atopic dermatitis	0.00305	0.00891	CbGbCtD
Valproic Acid—CYP3A4—Hydrocortisone—atopic dermatitis	0.00289	0.00845	CbGbCtD
Valproic Acid—CYP3A4—Prednisone—atopic dermatitis	0.00288	0.00841	CbGbCtD
Valproic Acid—CYP3A4—Dexamethasone—atopic dermatitis	0.0018	0.00525	CbGbCtD
Valproic Acid—SLC22A5—Temsirolimus—Tacrolimus—atopic dermatitis	0.000518	0.175	CbGdCrCtD
Valproic Acid—SLC22A5—Temsirolimus—Pimecrolimus—atopic dermatitis	0.000518	0.175	CbGdCrCtD
Valproic Acid—HDAC2—Sirolimus—Tacrolimus—atopic dermatitis	0.000317	0.107	CbGdCrCtD
Valproic Acid—HDAC2—Temsirolimus—Tacrolimus—atopic dermatitis	0.000317	0.107	CbGdCrCtD
Valproic Acid—HDAC2—Temsirolimus—Pimecrolimus—atopic dermatitis	0.000317	0.107	CbGdCrCtD
Valproic Acid—HDAC2—Everolimus—Tacrolimus—atopic dermatitis	0.000317	0.107	CbGdCrCtD
Valproic Acid—HDAC2—Sirolimus—Pimecrolimus—atopic dermatitis	0.000317	0.107	CbGdCrCtD
Valproic Acid—HDAC2—Everolimus—Pimecrolimus—atopic dermatitis	0.000317	0.107	CbGdCrCtD
Valproic Acid—HDAC2—p75NTR negatively regulates cell cycle via SC1—NGF—atopic dermatitis	0.000241	0.0534	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling by NOTCH—FCER2—atopic dermatitis	0.000199	0.044	CbGpPWpGaD
Valproic Acid—HDAC9—Initiation of transcription and translation elongation at the HIV-1 LTR—NFKBIA—atopic dermatitis	0.00012	0.0266	CbGpPWpGaD
Valproic Acid—HDAC2—Hedgehog signaling events mediated by Gli proteins—KIF3A—atopic dermatitis	0.00011	0.0244	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—FCER2—atopic dermatitis	8.61e-05	0.0191	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—IL13—atopic dermatitis	7.05e-05	0.0156	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	6.49e-05	0.0144	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—RELB—atopic dermatitis	6.48e-05	0.0143	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling events mediated by HDAC Class I—NFKBIA—atopic dermatitis	6.42e-05	0.0142	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—SELE—atopic dermatitis	5.78e-05	0.0128	CbGpPWpGaD
Valproic Acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	5.48e-05	0.0121	CbGpPWpGaD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—SELE—atopic dermatitis	5.43e-05	0.012	CbGpPWpGaD
Valproic Acid—HDAC2—Initiation of transcription and translation elongation at the HIV-1 LTR—NFKBIA—atopic dermatitis	5.21e-05	0.0115	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—IL13—atopic dermatitis	5.12e-05	0.0113	CbGpPWpGaD
Valproic Acid—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	5.07e-05	0.0112	CbGpPWpGaD
Valproic Acid—Malaise—Triamcinolone—atopic dermatitis	5.03e-05	0.00038	CcSEcCtD
Valproic Acid—Anxiety—Hydrocortisone—atopic dermatitis	5.03e-05	0.00038	CcSEcCtD
Valproic Acid—Malaise—Methylprednisolone—atopic dermatitis	5.02e-05	0.000379	CcSEcCtD
Valproic Acid—Vertigo—Triamcinolone—atopic dermatitis	5.01e-05	0.000379	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	5.01e-05	0.000379	CcSEcCtD
Valproic Acid—Vertigo—Methylprednisolone—atopic dermatitis	5e-05	0.000378	CcSEcCtD
Valproic Acid—Discomfort—Hydrocortisone—atopic dermatitis	4.98e-05	0.000377	CcSEcCtD
Valproic Acid—Connective tissue disorder—Prednisone—atopic dermatitis	4.98e-05	0.000376	CcSEcCtD
Valproic Acid—Oedema—Prednisolone—atopic dermatitis	4.95e-05	0.000374	CcSEcCtD
Valproic Acid—Anaphylactic shock—Prednisolone—atopic dermatitis	4.95e-05	0.000374	CcSEcCtD
Valproic Acid—Vomiting—Tacrolimus—atopic dermatitis	4.93e-05	0.000372	CcSEcCtD
Valproic Acid—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—atopic dermatitis	4.93e-05	0.0109	CbGpPWpGaD
Valproic Acid—UGT1A9—PPAR Alpha Pathway—PPARA—atopic dermatitis	4.9e-05	0.0109	CbGpPWpGaD
Valproic Acid—Rash—Tacrolimus—atopic dermatitis	4.89e-05	0.000369	CcSEcCtD
Valproic Acid—HDAC9—Cardiac Hypertrophic Response—MAPK8—atopic dermatitis	4.89e-05	0.0108	CbGpPWpGaD
Valproic Acid—Dermatitis—Tacrolimus—atopic dermatitis	4.88e-05	0.000369	CcSEcCtD
Valproic Acid—Cough—Triamcinolone—atopic dermatitis	4.87e-05	0.000368	CcSEcCtD
Valproic Acid—Headache—Tacrolimus—atopic dermatitis	4.86e-05	0.000367	CcSEcCtD
Valproic Acid—Anaphylactic shock—Hydrocortisone—atopic dermatitis	4.84e-05	0.000365	CcSEcCtD
Valproic Acid—Oedema—Hydrocortisone—atopic dermatitis	4.84e-05	0.000365	CcSEcCtD
Valproic Acid—Tachycardia—Prednisolone—atopic dermatitis	4.83e-05	0.000365	CcSEcCtD
Valproic Acid—Hypertension—Triamcinolone—atopic dermatitis	4.82e-05	0.000364	CcSEcCtD
Valproic Acid—Hypertension—Methylprednisolone—atopic dermatitis	4.81e-05	0.000363	CcSEcCtD
Valproic Acid—Infection—Hydrocortisone—atopic dermatitis	4.8e-05	0.000363	CcSEcCtD
Valproic Acid—Hyperhidrosis—Prednisolone—atopic dermatitis	4.79e-05	0.000362	CcSEcCtD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—KIF3A—atopic dermatitis	4.78e-05	0.0106	CbGpPWpGaD
Valproic Acid—Myalgia—Triamcinolone—atopic dermatitis	4.75e-05	0.000359	CcSEcCtD
Valproic Acid—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	4.75e-05	0.0105	CbGpPWpGaD
Valproic Acid—Nervous system disorder—Hydrocortisone—atopic dermatitis	4.74e-05	0.000358	CcSEcCtD
Valproic Acid—Myalgia—Methylprednisolone—atopic dermatitis	4.74e-05	0.000358	CcSEcCtD
Valproic Acid—Arthralgia—Methylprednisolone—atopic dermatitis	4.74e-05	0.000358	CcSEcCtD
Valproic Acid—Eye disorder—Prednisone—atopic dermatitis	4.73e-05	0.000358	CcSEcCtD
Valproic Acid—Anxiety—Methylprednisolone—atopic dermatitis	4.72e-05	0.000357	CcSEcCtD
Valproic Acid—Tachycardia—Hydrocortisone—atopic dermatitis	4.72e-05	0.000357	CcSEcCtD
Valproic Acid—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	4.71e-05	0.0104	CbGpPWpGaD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	4.71e-05	0.000356	CcSEcCtD
Valproic Acid—Skin disorder—Hydrocortisone—atopic dermatitis	4.7e-05	0.000355	CcSEcCtD
Valproic Acid—Ill-defined disorder—Betamethasone—atopic dermatitis	4.7e-05	0.000355	CcSEcCtD
Valproic Acid—Ill-defined disorder—Dexamethasone—atopic dermatitis	4.7e-05	0.000355	CcSEcCtD
Valproic Acid—Discomfort—Triamcinolone—atopic dermatitis	4.69e-05	0.000355	CcSEcCtD
Valproic Acid—Discomfort—Methylprednisolone—atopic dermatitis	4.68e-05	0.000354	CcSEcCtD
Valproic Acid—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.67e-05	0.000353	CcSEcCtD
Valproic Acid—Dry mouth—Triamcinolone—atopic dermatitis	4.64e-05	0.000351	CcSEcCtD
Valproic Acid—Angioedema—Betamethasone—atopic dermatitis	4.62e-05	0.00035	CcSEcCtD
Valproic Acid—Angioedema—Dexamethasone—atopic dermatitis	4.62e-05	0.00035	CcSEcCtD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	4.62e-05	0.0102	CbGpPWpGaD
Valproic Acid—Anorexia—Hydrocortisone—atopic dermatitis	4.61e-05	0.000348	CcSEcCtD
Valproic Acid—Nausea—Tacrolimus—atopic dermatitis	4.6e-05	0.000348	CcSEcCtD
Valproic Acid—Angiopathy—Prednisone—atopic dermatitis	4.59e-05	0.000347	CcSEcCtD
Valproic Acid—Confusional state—Methylprednisolone—atopic dermatitis	4.58e-05	0.000346	CcSEcCtD
Valproic Acid—Immune system disorder—Prednisone—atopic dermatitis	4.57e-05	0.000346	CcSEcCtD
Valproic Acid—Malaise—Betamethasone—atopic dermatitis	4.56e-05	0.000345	CcSEcCtD
Valproic Acid—Malaise—Dexamethasone—atopic dermatitis	4.56e-05	0.000345	CcSEcCtD
Valproic Acid—Oedema—Triamcinolone—atopic dermatitis	4.55e-05	0.000344	CcSEcCtD
Valproic Acid—Anaphylactic shock—Triamcinolone—atopic dermatitis	4.55e-05	0.000344	CcSEcCtD
Valproic Acid—Vertigo—Dexamethasone—atopic dermatitis	4.55e-05	0.000344	CcSEcCtD
Valproic Acid—Vertigo—Betamethasone—atopic dermatitis	4.55e-05	0.000344	CcSEcCtD
Valproic Acid—Anaphylactic shock—Methylprednisolone—atopic dermatitis	4.54e-05	0.000343	CcSEcCtD
Valproic Acid—Arrhythmia—Prednisone—atopic dermatitis	4.52e-05	0.000342	CcSEcCtD
Valproic Acid—Infection—Triamcinolone—atopic dermatitis	4.52e-05	0.000342	CcSEcCtD
Valproic Acid—Hypotension—Hydrocortisone—atopic dermatitis	4.52e-05	0.000341	CcSEcCtD
Valproic Acid—Infection—Methylprednisolone—atopic dermatitis	4.51e-05	0.000341	CcSEcCtD
Valproic Acid—Insomnia—Prednisolone—atopic dermatitis	4.48e-05	0.000338	CcSEcCtD
Valproic Acid—Alopecia—Prednisone—atopic dermatitis	4.47e-05	0.000338	CcSEcCtD
Valproic Acid—Nervous system disorder—Methylprednisolone—atopic dermatitis	4.45e-05	0.000337	CcSEcCtD
Valproic Acid—Paraesthesia—Prednisolone—atopic dermatitis	4.45e-05	0.000336	CcSEcCtD
Valproic Acid—Tachycardia—Triamcinolone—atopic dermatitis	4.44e-05	0.000336	CcSEcCtD
Valproic Acid—Mental disorder—Prednisone—atopic dermatitis	4.44e-05	0.000335	CcSEcCtD
Valproic Acid—Tachycardia—Methylprednisolone—atopic dermatitis	4.43e-05	0.000335	CcSEcCtD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—IL5—atopic dermatitis	4.42e-05	0.00979	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—IL10—atopic dermatitis	4.41e-05	0.00978	CbGpPWpGaD
Valproic Acid—Skin disorder—Methylprednisolone—atopic dermatitis	4.41e-05	0.000333	CcSEcCtD
Valproic Acid—Malnutrition—Prednisone—atopic dermatitis	4.41e-05	0.000333	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	4.41e-05	0.000333	CcSEcCtD
Valproic Acid—Hyperhidrosis—Triamcinolone—atopic dermatitis	4.4e-05	0.000333	CcSEcCtD
Valproic Acid—Hyperhidrosis—Methylprednisolone—atopic dermatitis	4.39e-05	0.000332	CcSEcCtD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—IL5—atopic dermatitis	4.38e-05	0.0097	CbGpPWpGaD
Valproic Acid—Insomnia—Hydrocortisone—atopic dermatitis	4.37e-05	0.00033	CcSEcCtD
Valproic Acid—Hypertension—Betamethasone—atopic dermatitis	4.37e-05	0.00033	CcSEcCtD
Valproic Acid—Hypertension—Dexamethasone—atopic dermatitis	4.37e-05	0.00033	CcSEcCtD
Valproic Acid—Paraesthesia—Hydrocortisone—atopic dermatitis	4.34e-05	0.000328	CcSEcCtD
Valproic Acid—Myalgia—Betamethasone—atopic dermatitis	4.31e-05	0.000326	CcSEcCtD
Valproic Acid—Myalgia—Dexamethasone—atopic dermatitis	4.31e-05	0.000326	CcSEcCtD
Valproic Acid—Anxiety—Dexamethasone—atopic dermatitis	4.29e-05	0.000325	CcSEcCtD
Valproic Acid—Anxiety—Betamethasone—atopic dermatitis	4.29e-05	0.000325	CcSEcCtD
Valproic Acid—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	4.26e-05	0.00943	CbGpPWpGaD
Valproic Acid—Discomfort—Dexamethasone—atopic dermatitis	4.26e-05	0.000322	CcSEcCtD
Valproic Acid—Discomfort—Betamethasone—atopic dermatitis	4.26e-05	0.000322	CcSEcCtD
Valproic Acid—Dyspepsia—Hydrocortisone—atopic dermatitis	4.26e-05	0.000322	CcSEcCtD
Valproic Acid—Hypotension—Methylprednisolone—atopic dermatitis	4.24e-05	0.000321	CcSEcCtD
Valproic Acid—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	4.24e-05	0.00938	CbGpPWpGaD
Valproic Acid—Pain—Prednisolone—atopic dermatitis	4.23e-05	0.00032	CcSEcCtD
Valproic Acid—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	4.22e-05	0.00935	CbGpPWpGaD
Valproic Acid—Decreased appetite—Hydrocortisone—atopic dermatitis	4.2e-05	0.000318	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	4.17e-05	0.000315	CcSEcCtD
Valproic Acid—Fatigue—Hydrocortisone—atopic dermatitis	4.17e-05	0.000315	CcSEcCtD
Valproic Acid—Vision blurred—Prednisone—atopic dermatitis	4.15e-05	0.000314	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	4.15e-05	0.000313	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	4.14e-05	0.000313	CcSEcCtD
Valproic Acid—Pain—Hydrocortisone—atopic dermatitis	4.13e-05	0.000312	CcSEcCtD
Valproic Acid—Oedema—Betamethasone—atopic dermatitis	4.13e-05	0.000312	CcSEcCtD
Valproic Acid—Anaphylactic shock—Betamethasone—atopic dermatitis	4.13e-05	0.000312	CcSEcCtD
Valproic Acid—Oedema—Dexamethasone—atopic dermatitis	4.13e-05	0.000312	CcSEcCtD
Valproic Acid—Anaphylactic shock—Dexamethasone—atopic dermatitis	4.13e-05	0.000312	CcSEcCtD
Valproic Acid—Insomnia—Triamcinolone—atopic dermatitis	4.12e-05	0.000311	CcSEcCtD
Valproic Acid—Insomnia—Methylprednisolone—atopic dermatitis	4.11e-05	0.000311	CcSEcCtD
Valproic Acid—Infection—Dexamethasone—atopic dermatitis	4.1e-05	0.00031	CcSEcCtD
Valproic Acid—Infection—Betamethasone—atopic dermatitis	4.1e-05	0.00031	CcSEcCtD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—NGF—atopic dermatitis	4.1e-05	0.00909	CbGpPWpGaD
Valproic Acid—Ill-defined disorder—Prednisone—atopic dermatitis	4.09e-05	0.000309	CcSEcCtD
Valproic Acid—Paraesthesia—Triamcinolone—atopic dermatitis	4.09e-05	0.000309	CcSEcCtD
Valproic Acid—Feeling abnormal—Prednisolone—atopic dermatitis	4.08e-05	0.000308	CcSEcCtD
Valproic Acid—Paraesthesia—Methylprednisolone—atopic dermatitis	4.08e-05	0.000308	CcSEcCtD
Valproic Acid—Anaemia—Prednisone—atopic dermatitis	4.07e-05	0.000308	CcSEcCtD
Valproic Acid—Dyspnoea—Triamcinolone—atopic dermatitis	4.06e-05	0.000307	CcSEcCtD
Valproic Acid—Nervous system disorder—Betamethasone—atopic dermatitis	4.05e-05	0.000306	CcSEcCtD
Valproic Acid—Nervous system disorder—Dexamethasone—atopic dermatitis	4.05e-05	0.000306	CcSEcCtD
Valproic Acid—Agitation—Prednisone—atopic dermatitis	4.05e-05	0.000306	CcSEcCtD
Valproic Acid—Thrombocytopenia—Dexamethasone—atopic dermatitis	4.04e-05	0.000306	CcSEcCtD
Valproic Acid—Thrombocytopenia—Betamethasone—atopic dermatitis	4.04e-05	0.000306	CcSEcCtD
Valproic Acid—Tachycardia—Dexamethasone—atopic dermatitis	4.03e-05	0.000305	CcSEcCtD
Valproic Acid—Tachycardia—Betamethasone—atopic dermatitis	4.03e-05	0.000305	CcSEcCtD
Valproic Acid—Angioedema—Prednisone—atopic dermatitis	4.03e-05	0.000304	CcSEcCtD
Valproic Acid—Dyspepsia—Triamcinolone—atopic dermatitis	4.01e-05	0.000303	CcSEcCtD
Valproic Acid—Dyspepsia—Methylprednisolone—atopic dermatitis	4e-05	0.000302	CcSEcCtD
Valproic Acid—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.99e-05	0.000302	CcSEcCtD
Valproic Acid—Hyperhidrosis—Betamethasone—atopic dermatitis	3.99e-05	0.000302	CcSEcCtD
Valproic Acid—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.98e-05	0.000301	CcSEcCtD
Valproic Acid—Malaise—Prednisone—atopic dermatitis	3.98e-05	0.0003	CcSEcCtD
Valproic Acid—Vertigo—Prednisone—atopic dermatitis	3.96e-05	0.000299	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.95e-05	0.000299	CcSEcCtD
Valproic Acid—Anorexia—Dexamethasone—atopic dermatitis	3.94e-05	0.000298	CcSEcCtD
Valproic Acid—Anorexia—Betamethasone—atopic dermatitis	3.94e-05	0.000298	CcSEcCtD
Valproic Acid—Urticaria—Prednisolone—atopic dermatitis	3.93e-05	0.000297	CcSEcCtD
Valproic Acid—Fatigue—Triamcinolone—atopic dermatitis	3.93e-05	0.000297	CcSEcCtD
Valproic Acid—Fatigue—Methylprednisolone—atopic dermatitis	3.92e-05	0.000296	CcSEcCtD
Valproic Acid—Pain—Triamcinolone—atopic dermatitis	3.89e-05	0.000294	CcSEcCtD
Valproic Acid—HDAC9—Cardiac Hypertrophic Response—TNF—atopic dermatitis	3.87e-05	0.00857	CbGpPWpGaD
Valproic Acid—Hypotension—Dexamethasone—atopic dermatitis	3.86e-05	0.000292	CcSEcCtD
Valproic Acid—Hypotension—Betamethasone—atopic dermatitis	3.86e-05	0.000292	CcSEcCtD
Valproic Acid—Urticaria—Hydrocortisone—atopic dermatitis	3.84e-05	0.00029	CcSEcCtD
Valproic Acid—Abdominal pain—Hydrocortisone—atopic dermatitis	3.82e-05	0.000289	CcSEcCtD
Valproic Acid—Body temperature increased—Hydrocortisone—atopic dermatitis	3.82e-05	0.000289	CcSEcCtD
Valproic Acid—Hypertension—Prednisone—atopic dermatitis	3.81e-05	0.000288	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.76e-05	0.000284	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.76e-05	0.000284	CcSEcCtD
Valproic Acid—Arthralgia—Prednisone—atopic dermatitis	3.75e-05	0.000284	CcSEcCtD
Valproic Acid—Myalgia—Prednisone—atopic dermatitis	3.75e-05	0.000284	CcSEcCtD
Valproic Acid—Feeling abnormal—Triamcinolone—atopic dermatitis	3.75e-05	0.000284	CcSEcCtD
Valproic Acid—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.74e-05	0.000283	CcSEcCtD
Valproic Acid—Anxiety—Prednisone—atopic dermatitis	3.74e-05	0.000283	CcSEcCtD
Valproic Acid—Insomnia—Betamethasone—atopic dermatitis	3.74e-05	0.000282	CcSEcCtD
Valproic Acid—Insomnia—Dexamethasone—atopic dermatitis	3.74e-05	0.000282	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	3.73e-05	0.000282	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.71e-05	0.000281	CcSEcCtD
Valproic Acid—Paraesthesia—Dexamethasone—atopic dermatitis	3.71e-05	0.00028	CcSEcCtD
Valproic Acid—Paraesthesia—Betamethasone—atopic dermatitis	3.71e-05	0.00028	CcSEcCtD
Valproic Acid—Discomfort—Prednisone—atopic dermatitis	3.71e-05	0.00028	CcSEcCtD
Valproic Acid—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	3.67e-05	0.00812	CbGpPWpGaD
Valproic Acid—Hypersensitivity—Prednisolone—atopic dermatitis	3.65e-05	0.000276	CcSEcCtD
Valproic Acid—Dyspepsia—Dexamethasone—atopic dermatitis	3.64e-05	0.000275	CcSEcCtD
Valproic Acid—Dyspepsia—Betamethasone—atopic dermatitis	3.64e-05	0.000275	CcSEcCtD
Valproic Acid—Urticaria—Triamcinolone—atopic dermatitis	3.62e-05	0.000273	CcSEcCtD
Valproic Acid—Urticaria—Methylprednisolone—atopic dermatitis	3.61e-05	0.000273	CcSEcCtD
Valproic Acid—Body temperature increased—Triamcinolone—atopic dermatitis	3.6e-05	0.000272	CcSEcCtD
Valproic Acid—Oedema—Prednisone—atopic dermatitis	3.6e-05	0.000272	CcSEcCtD
Valproic Acid—Anaphylactic shock—Prednisone—atopic dermatitis	3.6e-05	0.000272	CcSEcCtD
Valproic Acid—Abdominal pain—Methylprednisolone—atopic dermatitis	3.59e-05	0.000271	CcSEcCtD
Valproic Acid—Decreased appetite—Betamethasone—atopic dermatitis	3.59e-05	0.000271	CcSEcCtD
Valproic Acid—Decreased appetite—Dexamethasone—atopic dermatitis	3.59e-05	0.000271	CcSEcCtD
Valproic Acid—Infection—Prednisone—atopic dermatitis	3.57e-05	0.00027	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Betamethasone—atopic dermatitis	3.57e-05	0.00027	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	3.57e-05	0.00027	CcSEcCtD
Valproic Acid—Hypersensitivity—Hydrocortisone—atopic dermatitis	3.56e-05	0.000269	CcSEcCtD
Valproic Acid—Fatigue—Dexamethasone—atopic dermatitis	3.56e-05	0.000269	CcSEcCtD
Valproic Acid—Fatigue—Betamethasone—atopic dermatitis	3.56e-05	0.000269	CcSEcCtD
Valproic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	3.55e-05	0.00787	CbGpPWpGaD
Valproic Acid—Pain—Betamethasone—atopic dermatitis	3.53e-05	0.000267	CcSEcCtD
Valproic Acid—Pain—Dexamethasone—atopic dermatitis	3.53e-05	0.000267	CcSEcCtD
Valproic Acid—Nervous system disorder—Prednisone—atopic dermatitis	3.53e-05	0.000267	CcSEcCtD
Valproic Acid—Tachycardia—Prednisone—atopic dermatitis	3.51e-05	0.000265	CcSEcCtD
Valproic Acid—Skin disorder—Prednisone—atopic dermatitis	3.49e-05	0.000264	CcSEcCtD
Valproic Acid—HDAC9—MicroRNAs in cardiomyocyte hypertrophy—MAPK8—atopic dermatitis	3.48e-05	0.00771	CbGpPWpGaD
Valproic Acid—Hyperhidrosis—Prednisone—atopic dermatitis	3.48e-05	0.000263	CcSEcCtD
Valproic Acid—Asthenia—Hydrocortisone—atopic dermatitis	3.47e-05	0.000262	CcSEcCtD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	3.44e-05	0.00763	CbGpPWpGaD
Valproic Acid—Anorexia—Prednisone—atopic dermatitis	3.43e-05	0.000259	CcSEcCtD
Valproic Acid—Pruritus—Hydrocortisone—atopic dermatitis	3.42e-05	0.000259	CcSEcCtD
Valproic Acid—Feeling abnormal—Dexamethasone—atopic dermatitis	3.4e-05	0.000257	CcSEcCtD
Valproic Acid—Feeling abnormal—Betamethasone—atopic dermatitis	3.4e-05	0.000257	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.38e-05	0.000255	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.38e-05	0.000255	CcSEcCtD
Valproic Acid—Hypersensitivity—Triamcinolone—atopic dermatitis	3.35e-05	0.000253	CcSEcCtD
Valproic Acid—ACADSB—Metabolism—GLB1—atopic dermatitis	3.35e-05	0.00743	CbGpPWpGaD
Valproic Acid—Hypersensitivity—Methylprednisolone—atopic dermatitis	3.35e-05	0.000253	CcSEcCtD
Valproic Acid—Diarrhoea—Hydrocortisone—atopic dermatitis	3.31e-05	0.00025	CcSEcCtD
Valproic Acid—Urticaria—Dexamethasone—atopic dermatitis	3.28e-05	0.000248	CcSEcCtD
Valproic Acid—Urticaria—Betamethasone—atopic dermatitis	3.28e-05	0.000248	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Prednisone—atopic dermatitis	3.28e-05	0.000248	CcSEcCtD
Valproic Acid—Dizziness—Prednisolone—atopic dermatitis	3.27e-05	0.000247	CcSEcCtD
Valproic Acid—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	3.27e-05	0.00724	CbGpPWpGaD
Valproic Acid—Asthenia—Triamcinolone—atopic dermatitis	3.27e-05	0.000247	CcSEcCtD
Valproic Acid—Body temperature increased—Dexamethasone—atopic dermatitis	3.27e-05	0.000247	CcSEcCtD
Valproic Acid—Abdominal pain—Betamethasone—atopic dermatitis	3.27e-05	0.000247	CcSEcCtD
Valproic Acid—Abdominal pain—Dexamethasone—atopic dermatitis	3.27e-05	0.000247	CcSEcCtD
Valproic Acid—Body temperature increased—Betamethasone—atopic dermatitis	3.27e-05	0.000247	CcSEcCtD
Valproic Acid—Asthenia—Methylprednisolone—atopic dermatitis	3.26e-05	0.000246	CcSEcCtD
Valproic Acid—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	3.26e-05	0.00722	CbGpPWpGaD
Valproic Acid—Insomnia—Prednisone—atopic dermatitis	3.25e-05	0.000246	CcSEcCtD
Valproic Acid—PTGS1—Overview of nanoparticle effects—CXCL8—atopic dermatitis	3.24e-05	0.00717	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—IL10—atopic dermatitis	3.23e-05	0.00716	CbGpPWpGaD
Valproic Acid—Paraesthesia—Prednisone—atopic dermatitis	3.23e-05	0.000244	CcSEcCtD
Valproic Acid—Pruritus—Triamcinolone—atopic dermatitis	3.22e-05	0.000243	CcSEcCtD
Valproic Acid—Pruritus—Methylprednisolone—atopic dermatitis	3.21e-05	0.000243	CcSEcCtD
Valproic Acid—ACADSB—Metabolism—ADSL—atopic dermatitis	3.21e-05	0.00712	CbGpPWpGaD
Valproic Acid—Dizziness—Hydrocortisone—atopic dermatitis	3.2e-05	0.000242	CcSEcCtD
Valproic Acid—HDAC9—Signaling events mediated by HDAC Class I—TNF—atopic dermatitis	3.19e-05	0.00706	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	3.19e-05	0.00706	CbGpPWpGaD
Valproic Acid—Dyspepsia—Prednisone—atopic dermatitis	3.17e-05	0.000239	CcSEcCtD
Valproic Acid—Decreased appetite—Prednisone—atopic dermatitis	3.13e-05	0.000236	CcSEcCtD
Valproic Acid—CYP1A2—Estrogen Receptor Pathway—PPARA—atopic dermatitis	3.12e-05	0.00692	CbGpPWpGaD
Valproic Acid—Rash—Prednisolone—atopic dermatitis	3.12e-05	0.000236	CcSEcCtD
Valproic Acid—Dermatitis—Prednisolone—atopic dermatitis	3.12e-05	0.000236	CcSEcCtD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—IL4—atopic dermatitis	3.11e-05	0.0069	CbGpPWpGaD
Valproic Acid—Diarrhoea—Methylprednisolone—atopic dermatitis	3.11e-05	0.000235	CcSEcCtD
Valproic Acid—Fatigue—Prednisone—atopic dermatitis	3.1e-05	0.000234	CcSEcCtD
Valproic Acid—Headache—Prednisolone—atopic dermatitis	3.1e-05	0.000234	CcSEcCtD
Valproic Acid—Constipation—Prednisone—atopic dermatitis	3.08e-05	0.000232	CcSEcCtD
Valproic Acid—Vomiting—Hydrocortisone—atopic dermatitis	3.07e-05	0.000232	CcSEcCtD
Valproic Acid—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	3.07e-05	0.00681	CbGpPWpGaD
Valproic Acid—HDAC2—Levonorgestrel—Hydrocortisone—atopic dermatitis	3.06e-05	0.0103	CbGdCrCtD
Valproic Acid—Rash—Hydrocortisone—atopic dermatitis	3.05e-05	0.00023	CcSEcCtD
Valproic Acid—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	3.05e-05	0.00675	CbGpPWpGaD
Valproic Acid—Dermatitis—Hydrocortisone—atopic dermatitis	3.05e-05	0.00023	CcSEcCtD
Valproic Acid—Headache—Hydrocortisone—atopic dermatitis	3.03e-05	0.000229	CcSEcCtD
Valproic Acid—Dizziness—Triamcinolone—atopic dermatitis	3.01e-05	0.000228	CcSEcCtD
Valproic Acid—HDAC2—Direct p53 effectors—CASP1—atopic dermatitis	3.01e-05	0.00667	CbGpPWpGaD
Valproic Acid—Dizziness—Methylprednisolone—atopic dermatitis	3e-05	0.000227	CcSEcCtD
Valproic Acid—HDAC2—p75 NTR receptor-mediated signalling—NGF—atopic dermatitis	2.98e-05	0.00659	CbGpPWpGaD
Valproic Acid—Feeling abnormal—Prednisone—atopic dermatitis	2.96e-05	0.000224	CcSEcCtD
Valproic Acid—Asthenia—Dexamethasone—atopic dermatitis	2.96e-05	0.000224	CcSEcCtD
Valproic Acid—Asthenia—Betamethasone—atopic dermatitis	2.96e-05	0.000224	CcSEcCtD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	2.96e-05	0.00656	CbGpPWpGaD
Valproic Acid—Gastrointestinal pain—Prednisone—atopic dermatitis	2.94e-05	0.000222	CcSEcCtD
Valproic Acid—Nausea—Prednisolone—atopic dermatitis	2.94e-05	0.000222	CcSEcCtD
Valproic Acid—Pruritus—Betamethasone—atopic dermatitis	2.92e-05	0.000221	CcSEcCtD
Valproic Acid—Pruritus—Dexamethasone—atopic dermatitis	2.92e-05	0.000221	CcSEcCtD
Valproic Acid—Vomiting—Triamcinolone—atopic dermatitis	2.89e-05	0.000219	CcSEcCtD
Valproic Acid—Vomiting—Methylprednisolone—atopic dermatitis	2.89e-05	0.000218	CcSEcCtD
Valproic Acid—Nausea—Hydrocortisone—atopic dermatitis	2.87e-05	0.000217	CcSEcCtD
Valproic Acid—Rash—Triamcinolone—atopic dermatitis	2.87e-05	0.000217	CcSEcCtD
Valproic Acid—Dermatitis—Triamcinolone—atopic dermatitis	2.87e-05	0.000217	CcSEcCtD
Valproic Acid—Rash—Methylprednisolone—atopic dermatitis	2.86e-05	0.000216	CcSEcCtD
Valproic Acid—Dermatitis—Methylprednisolone—atopic dermatitis	2.86e-05	0.000216	CcSEcCtD
Valproic Acid—Urticaria—Prednisone—atopic dermatitis	2.86e-05	0.000216	CcSEcCtD
Valproic Acid—Headache—Triamcinolone—atopic dermatitis	2.85e-05	0.000216	CcSEcCtD
Valproic Acid—OGDH—Metabolism—GLB1—atopic dermatitis	2.85e-05	0.00631	CbGpPWpGaD
Valproic Acid—Headache—Methylprednisolone—atopic dermatitis	2.85e-05	0.000215	CcSEcCtD
Valproic Acid—Abdominal pain—Prednisone—atopic dermatitis	2.84e-05	0.000215	CcSEcCtD
Valproic Acid—Body temperature increased—Prednisone—atopic dermatitis	2.84e-05	0.000215	CcSEcCtD
Valproic Acid—Diarrhoea—Betamethasone—atopic dermatitis	2.83e-05	0.000214	CcSEcCtD
Valproic Acid—Diarrhoea—Dexamethasone—atopic dermatitis	2.83e-05	0.000214	CcSEcCtD
Valproic Acid—HDAC2—Signaling events mediated by HDAC Class I—NFKBIA—atopic dermatitis	2.79e-05	0.00617	CbGpPWpGaD
Valproic Acid—HDAC9—MicroRNAs in cardiomyocyte hypertrophy—TNF—atopic dermatitis	2.76e-05	0.0061	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—ADSL—atopic dermatitis	2.73e-05	0.00605	CbGpPWpGaD
Valproic Acid—Dizziness—Dexamethasone—atopic dermatitis	2.73e-05	0.000206	CcSEcCtD
Valproic Acid—Dizziness—Betamethasone—atopic dermatitis	2.73e-05	0.000206	CcSEcCtD
Valproic Acid—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	2.72e-05	0.00602	CbGpPWpGaD
Valproic Acid—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	2.71e-05	0.006	CbGpPWpGaD
Valproic Acid—Nausea—Triamcinolone—atopic dermatitis	2.7e-05	0.000204	CcSEcCtD
Valproic Acid—Nausea—Methylprednisolone—atopic dermatitis	2.7e-05	0.000204	CcSEcCtD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	2.68e-05	0.00593	CbGpPWpGaD
Valproic Acid—Hypersensitivity—Prednisone—atopic dermatitis	2.65e-05	0.0002	CcSEcCtD
Valproic Acid—Vomiting—Betamethasone—atopic dermatitis	2.63e-05	0.000198	CcSEcCtD
Valproic Acid—Vomiting—Dexamethasone—atopic dermatitis	2.63e-05	0.000198	CcSEcCtD
Valproic Acid—Rash—Dexamethasone—atopic dermatitis	2.6e-05	0.000197	CcSEcCtD
Valproic Acid—Rash—Betamethasone—atopic dermatitis	2.6e-05	0.000197	CcSEcCtD
Valproic Acid—Dermatitis—Betamethasone—atopic dermatitis	2.6e-05	0.000197	CcSEcCtD
Valproic Acid—Dermatitis—Dexamethasone—atopic dermatitis	2.6e-05	0.000197	CcSEcCtD
Valproic Acid—Headache—Betamethasone—atopic dermatitis	2.59e-05	0.000196	CcSEcCtD
Valproic Acid—Headache—Dexamethasone—atopic dermatitis	2.59e-05	0.000196	CcSEcCtD
Valproic Acid—Asthenia—Prednisone—atopic dermatitis	2.58e-05	0.000195	CcSEcCtD
Valproic Acid—Pruritus—Prednisone—atopic dermatitis	2.55e-05	0.000192	CcSEcCtD
Valproic Acid—SLC16A1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	2.49e-05	0.00551	CbGpPWpGaD
Valproic Acid—Diarrhoea—Prednisone—atopic dermatitis	2.46e-05	0.000186	CcSEcCtD
Valproic Acid—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.46e-05	0.00545	CbGpPWpGaD
Valproic Acid—HDAC2—p75 NTR receptor-mediated signalling—NFKBIA—atopic dermatitis	2.45e-05	0.00544	CbGpPWpGaD
Valproic Acid—Nausea—Dexamethasone—atopic dermatitis	2.45e-05	0.000185	CcSEcCtD
Valproic Acid—Nausea—Betamethasone—atopic dermatitis	2.45e-05	0.000185	CcSEcCtD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	2.41e-05	0.00534	CbGpPWpGaD
Valproic Acid—Dizziness—Prednisone—atopic dermatitis	2.38e-05	0.00018	CcSEcCtD
Valproic Acid—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	2.37e-05	0.00526	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	2.31e-05	0.00513	CbGpPWpGaD
Valproic Acid—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	2.3e-05	0.0051	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—NPS—atopic dermatitis	2.3e-05	0.00509	CbGpPWpGaD
Valproic Acid—Vomiting—Prednisone—atopic dermatitis	2.29e-05	0.000173	CcSEcCtD
Valproic Acid—Rash—Prednisone—atopic dermatitis	2.27e-05	0.000171	CcSEcCtD
Valproic Acid—Dermatitis—Prednisone—atopic dermatitis	2.27e-05	0.000171	CcSEcCtD
Valproic Acid—PTGS1—Overview of nanoparticle effects—TNF—atopic dermatitis	2.25e-05	0.00499	CbGpPWpGaD
Valproic Acid—Headache—Prednisone—atopic dermatitis	2.25e-05	0.00017	CcSEcCtD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	2.24e-05	0.00495	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—GLB1—atopic dermatitis	2.23e-05	0.00493	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of Telomerase—IFNG—atopic dermatitis	2.19e-05	0.00484	CbGpPWpGaD
Valproic Acid—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	2.14e-05	0.00474	CbGpPWpGaD
Valproic Acid—Nausea—Prednisone—atopic dermatitis	2.14e-05	0.000161	CcSEcCtD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	2.11e-05	0.00466	CbGpPWpGaD
Valproic Acid—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	1.97e-05	0.00437	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—FCER2—atopic dermatitis	1.97e-05	0.00437	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of Telomerase—IL2—atopic dermatitis	1.94e-05	0.0043	CbGpPWpGaD
Valproic Acid—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	1.94e-05	0.00429	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—IFNG—atopic dermatitis	1.88e-05	0.00417	CbGpPWpGaD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	1.88e-05	0.00416	CbGpPWpGaD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	1.87e-05	0.00415	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCL22—atopic dermatitis	1.83e-05	0.00406	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—KIF3A—atopic dermatitis	1.83e-05	0.00405	CbGpPWpGaD
Valproic Acid—PTGS1—Overview of nanoparticle effects—IL6—atopic dermatitis	1.82e-05	0.00403	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—atopic dermatitis	1.78e-05	0.00395	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—GLB1—atopic dermatitis	1.76e-05	0.0039	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—CXCL8—atopic dermatitis	1.75e-05	0.00388	CbGpPWpGaD
Valproic Acid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	1.69e-05	0.00375	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—ADSL—atopic dermatitis	1.69e-05	0.00374	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—TNF—atopic dermatitis	1.68e-05	0.00372	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—IL2—atopic dermatitis	1.67e-05	0.0037	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—KIF3A—atopic dermatitis	1.67e-05	0.0037	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCL27—atopic dermatitis	1.63e-05	0.00362	CbGpPWpGaD
Valproic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	1.61e-05	0.00358	CbGpPWpGaD
Valproic Acid—UGT1A9—PPARA activates gene expression—PPARA—atopic dermatitis	1.55e-05	0.00342	CbGpPWpGaD
Valproic Acid—HDAC2—p75 NTR receptor-mediated signalling—MAPK8—atopic dermatitis	1.54e-05	0.00341	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—MAPK8—atopic dermatitis	1.54e-05	0.00341	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—GLB1—atopic dermatitis	1.54e-05	0.00341	CbGpPWpGaD
Valproic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	1.51e-05	0.00335	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—SLC11A1—atopic dermatitis	1.49e-05	0.0033	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—ADSL—atopic dermatitis	1.48e-05	0.00327	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—SELE—atopic dermatitis	1.47e-05	0.00326	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCL17—atopic dermatitis	1.47e-05	0.00325	CbGpPWpGaD
Valproic Acid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	1.45e-05	0.00321	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling events mediated by HDAC Class I—TNF—atopic dermatitis	1.38e-05	0.00306	CbGpPWpGaD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	1.36e-05	0.00302	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.36e-05	0.003	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—PPARA—atopic dermatitis	1.35e-05	0.003	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—SELE—atopic dermatitis	1.35e-05	0.00298	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KIF3A—atopic dermatitis	1.31e-05	0.00289	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—GLB1—atopic dermatitis	1.28e-05	0.00285	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.28e-05	0.00283	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.26e-05	0.0028	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—ADSL—atopic dermatitis	1.23e-05	0.00273	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCL11—atopic dermatitis	1.18e-05	0.00262	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CMA1—atopic dermatitis	1.18e-05	0.00262	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.17e-05	0.00259	CbGpPWpGaD
Valproic Acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	1.12e-05	0.00248	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—IL5—atopic dermatitis	1.12e-05	0.00247	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—STAT6—atopic dermatitis	1.11e-05	0.00246	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—NGF—atopic dermatitis	1.1e-05	0.00243	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—PPARA—atopic dermatitis	1.09e-05	0.00241	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.09e-05	0.00241	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.04e-05	0.00231	CbGpPWpGaD
Valproic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	1.04e-05	0.00231	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—IFNG—atopic dermatitis	1.02e-05	0.00226	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—IL5—atopic dermatitis	1.02e-05	0.00226	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GLB1—atopic dermatitis	9.92e-06	0.0022	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	9.83e-06	0.00218	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—IL6—atopic dermatitis	9.83e-06	0.00218	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—GLB1—atopic dermatitis	9.65e-06	0.00214	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCR3—atopic dermatitis	9.63e-06	0.00213	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ADSL—atopic dermatitis	9.51e-06	0.00211	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—PPARA—atopic dermatitis	9.25e-06	0.00205	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—IL1B—atopic dermatitis	9.11e-06	0.00202	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—NFKBIA—atopic dermatitis	9.03e-06	0.002	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GLB1—atopic dermatitis	8.84e-06	0.00196	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TAC1—atopic dermatitis	8.59e-06	0.0019	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NPS—atopic dermatitis	8.59e-06	0.0019	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FCER2—atopic dermatitis	8.55e-06	0.00189	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ADSL—atopic dermatitis	8.48e-06	0.00188	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CXCR3—atopic dermatitis	8.42e-06	0.00187	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GLB1—atopic dermatitis	8.24e-06	0.00183	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	8.21e-06	0.00182	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL5—atopic dermatitis	7.98e-06	0.00177	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCL22—atopic dermatitis	7.95e-06	0.00176	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ADSL—atopic dermatitis	7.9e-06	0.00175	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	7.71e-06	0.00171	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CCR5—atopic dermatitis	7.54e-06	0.00167	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—MAPK8—atopic dermatitis	7.51e-06	0.00166	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GLB1—atopic dermatitis	7.21e-06	0.0016	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCL27—atopic dermatitis	7.09e-06	0.00157	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GLB1—atopic dermatitis	7.01e-06	0.00155	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ADSL—atopic dermatitis	6.91e-06	0.00153	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	6.88e-06	0.00152	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	6.85e-06	0.00152	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CXCL10—atopic dermatitis	6.81e-06	0.00151	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.74e-06	0.00149	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ADSL—atopic dermatitis	6.72e-06	0.00149	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—TNF—atopic dermatitis	6.61e-06	0.00146	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SLC11A1—atopic dermatitis	6.47e-06	0.00143	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCL17—atopic dermatitis	6.36e-06	0.00141	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	6.13e-06	0.00136	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.01e-06	0.00133	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCL5—atopic dermatitis	5.86e-06	0.0013	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PPARA—atopic dermatitis	5.71e-06	0.00127	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GLB1—atopic dermatitis	5.7e-06	0.00126	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.67e-06	0.00126	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—MAPK8—atopic dermatitis	5.67e-06	0.00126	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KIF3A—atopic dermatitis	5.67e-06	0.00126	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.48e-06	0.00121	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ADSL—atopic dermatitis	5.46e-06	0.00121	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NGF—atopic dermatitis	5.43e-06	0.0012	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—IL6—atopic dermatitis	5.34e-06	0.00118	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCR5—atopic dermatitis	5.28e-06	0.00117	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.27e-06	0.00117	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCL11—atopic dermatitis	5.12e-06	0.00113	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CMA1—atopic dermatitis	5.12e-06	0.00113	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PPARA—atopic dermatitis	4.99e-06	0.00111	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	4.99e-06	0.00111	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	4.99e-06	0.00111	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STAT6—atopic dermatitis	4.82e-06	0.00107	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—IL6—atopic dermatitis	4.8e-06	0.00106	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.76e-06	0.00106	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CD4—atopic dermatitis	4.73e-06	0.00105	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.68e-06	0.00104	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GLB1—atopic dermatitis	4.64e-06	0.00103	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NFKBIA—atopic dermatitis	4.47e-06	0.000991	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ADSL—atopic dermatitis	4.45e-06	0.000986	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GLB1—atopic dermatitis	4.39e-06	0.000973	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—IL2—atopic dermatitis	4.26e-06	0.000945	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ADSL—atopic dermatitis	4.21e-06	0.000933	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCR3—atopic dermatitis	4.18e-06	0.000925	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PPARA—atopic dermatitis	4.17e-06	0.000924	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.15e-06	0.00092	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.98e-06	0.000881	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—IL2—atopic dermatitis	3.9e-06	0.000864	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TAC1—atopic dermatitis	3.72e-06	0.000825	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NPS—atopic dermatitis	3.72e-06	0.000825	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCR3—atopic dermatitis	3.65e-06	0.000809	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—IL6—atopic dermatitis	3.62e-06	0.000802	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GLB1—atopic dermatitis	3.54e-06	0.000785	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GLB1—atopic dermatitis	3.46e-06	0.000767	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL5—atopic dermatitis	3.46e-06	0.000767	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ADSL—atopic dermatitis	3.4e-06	0.000752	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.38e-06	0.00075	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—PPARA—atopic dermatitis	3.37e-06	0.000748	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ADSL—atopic dermatitis	3.32e-06	0.000735	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CCR5—atopic dermatitis	3.27e-06	0.000724	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PPARA—atopic dermatitis	3.22e-06	0.000713	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CXCL8—atopic dermatitis	3.19e-06	0.000707	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL2—atopic dermatitis	3.05e-06	0.000676	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GLB1—atopic dermatitis	3e-06	0.000664	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL10—atopic dermatitis	2.95e-06	0.000654	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ADSL—atopic dermatitis	2.88e-06	0.000637	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PPARA—atopic dermatitis	2.87e-06	0.000636	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MAPK8—atopic dermatitis	2.81e-06	0.000622	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GLB1—atopic dermatitis	2.68e-06	0.000593	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PPARA—atopic dermatitis	2.68e-06	0.000593	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ADSL—atopic dermatitis	2.57e-06	0.000569	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—IL6—atopic dermatitis	2.56e-06	0.000567	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCL5—atopic dermatitis	2.54e-06	0.000563	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GLB1—atopic dermatitis	2.44e-06	0.000541	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NGF—atopic dermatitis	2.35e-06	0.000521	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ADSL—atopic dermatitis	2.34e-06	0.000518	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PPARA—atopic dermatitis	2.34e-06	0.000518	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCR5—atopic dermatitis	2.29e-06	0.000507	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PPARA—atopic dermatitis	2.27e-06	0.000504	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.19e-06	0.000484	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GLB1—atopic dermatitis	2.09e-06	0.000462	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CD4—atopic dermatitis	2.05e-06	0.000455	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ADSL—atopic dermatitis	2e-06	0.000443	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.95e-06	0.000432	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NFKBIA—atopic dermatitis	1.94e-06	0.00043	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PPARA—atopic dermatitis	1.85e-06	0.00041	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL6—atopic dermatitis	1.79e-06	0.000397	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.78e-06	0.000394	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.61e-06	0.000357	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.54e-06	0.000342	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.52e-06	0.000337	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PPARA—atopic dermatitis	1.51e-06	0.000334	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PPARA—atopic dermatitis	1.43e-06	0.000316	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL8—atopic dermatitis	1.38e-06	0.000306	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL2—atopic dermatitis	1.32e-06	0.000293	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK8—atopic dermatitis	1.22e-06	0.00027	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPARA—atopic dermatitis	1.15e-06	0.000255	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPARA—atopic dermatitis	1.12e-06	0.000249	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—atopic dermatitis	1.11e-06	0.000246	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPARA—atopic dermatitis	9.73e-07	0.000216	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPARA—atopic dermatitis	8.69e-07	0.000192	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPARA—atopic dermatitis	7.92e-07	0.000176	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—atopic dermatitis	7.77e-07	0.000172	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPARA—atopic dermatitis	6.77e-07	0.00015	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPARA—atopic dermatitis	5.22e-07	0.000116	CbGpPWpGaD
